Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

vensica.com

Total Raised

$21.5M

Investors Count

7

Deal Terms

1

Vensica Therapeutics Funding, Vensica Therapeutics Valuation & Vensica Therapeutics Revenue

5 Fundings

Vensica Therapeutics's latest funding round was a Series B - II for $3M on February 7, 2022.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

2/7/2022

Series B - II

$3M

0

FY undefined

6

11/1/2021

Series B

$99M

0

FY undefined

10

9/28/2017

Series A

$99M

0

FY undefined

10

7/19/2016

Seed

$99M

0

FY undefined

10

Other Investors

0

FY undefined

0

Date

2/7/2022

11/1/2021

9/28/2017

7/19/2016

Round

Series B - II

Series B

Series A

Seed

Other Investors

Amount

$3M

$99M

$99M

$99M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

6

10

10

10

0

Vensica Therapeutics Deal Terms

1 Deal Term

Vensica Therapeutics's deal structure is available for 1 funding round, including their Series A from September 28, 2017.

Round

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$99M

$99M

$99M

$99M

Vensica Therapeutics Investors

7 Investors

Vensica Therapeutics has 7 investors. Merz Therapeutics invested in Vensica Therapeutics's Series B - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

2/7/2022

2/7/2022

1
Series B - II

Corporation

Germany

00/00/0000

00/00/0000

The Trendlines Group

Subscribe to see more

Venture Capital

Israel

00/00/0000

00/00/0000

Laborie Medical Technologies

Subscribe to see more

Corporation

Canada

00/00/0000

00/00/0000

Israel Biotech Fund

Subscribe to see more

Venture Capital

Israel

00/00/0000

00/00/0000

Agriline

Subscribe to see more

Corporation

United Kingdom

First funding

2/7/2022

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

2/7/2022

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

The Trendlines Group

Laborie Medical Technologies

Israel Biotech Fund

Agriline

Rounds

1
Series B - II

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Corporation

Venture Capital

Corporation

Location

Germany

Israel

Canada

Israel

United Kingdom

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.